Fernando M. Rodrigues - 01 Sep 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Sep 2026, 16:05:11 UTC
Prior SEC filing
04 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Fernando M. Rodrigues filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Sep 2026.

Key facts

  • This page summarizes Fernando M. Rodrigues's Form 4 filing for Teladoc Health, Inc. (TDOC).
  • 8 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 04 Jun 2026.
  • Current net transaction value: -$98,147.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037547 Primary reporting owner

Rodrigues Fernando M.

Relationship
President of BetterHelp
Address
C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date
03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,492
Change %
Price
Shares after
5,492
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,042
Change %
+19%
Price
Shares after
6,534
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares
+8,717
Change %
+133%
Price
Shares after
15,251
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1
TDOC transaction

Common Stock

Sale

Transaction value
$34,271
Shares
-5,439
Change %
-36%
Price
$6.30
Shares after
9,812
Date
02 Sep 2026
Ownership
Direct
Footnotes
F2
TDOC transaction

Common Stock

Sale

Transaction value
$63,876
Shares
-9,812
Change %
-100%
Price
$6.51
Shares after
0
Date
03 Sep 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-5,492
Change %
-50%
Price
$0.000000*
Shares after
5,492
Date
01 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,492
Exercise price
Footnotes
F1, F4
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,042
Change %
-33%
Price
$0.000000*
Shares after
2,084
Date
01 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,042
Exercise price
Footnotes
F1, F5
TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-8,717
Change %
-14%
Price
$0.000000*
Shares after
52,302
Date
01 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,717
Exercise price
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Footnote F3

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 3, 2025.

Footnote F4

On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F5

On March 19, 2024, the reporting person was granted 12,500 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

Footnote F6

On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .